Ling obtained her PhD in pharmacology and therapeutics from McGill University, Canada. Her research focused on the molecular regulation of human cardiac electrophysiologic diseases with an interest in understanding the genetic basis of cardiac arrhythmias. She joined MGH CVRC in 2014, initially as a research fellow in the laboratory of Dr. David Milan and is currently promoted to instructor under the mentorship of Dr. Patrick Ellinor. Her current research has focused on 1) functional genomics using the human pluripotent stem cell model and CRIPSR gene editing technologies; 2) the role of cardiac immune cells in cardiac arrhymias; 3) cardio-oncology to understand the mechanisms of small molecule of tyrosine kinase inhibitors induced cardiotoxicity; and 4) the role of novel cardiac cell types identified through single-cell RNAseq in cardiac homeostasis and pathology.